Pfizer Inc. said a new version of its bestselling Prevnar vaccine may provide infants with better protection against common ...
18hon MSN
Pfizer begins late-stage trial for new pneumococcal shot in infants after strong phase 2 data
Pfizer (PFE) on Wednesday announced that it has begun a Phase 3 trial for its 25-valent pneumococcal vaccine, PF-07872412 (25vPnC), for infants after the shot outperformed its pneumococcal 20-valent ...
Super Bowl ads are a show within the show, an opportunity for brands and advertising creatives to put their work in front of more than 100 million viewers. And while the occasion is most closely ...
Pfizer, Anthropic and longevity scientists position AI as healthcare's core infrastructure, accelerating drug design and care.
Pfizer worldwide research and development president Mikael Dolsten leaves after appearing at a commons science committee hearing at Portcullis House in London (Reuters) -Pfizer said on Tuesday Chief ...
NEW YORK, June 24 /PRNewswire/ — Underscoring its commitment to scientific advancement, Pfizer Inc will launch Think Science Now, a science awareness program to promote exceptional researchers who ...
Pfizer’s School of Science Mobile Experience rolled into McPherson this week, offering local students a one-of-a-kind opportunity to explore the wonders of science through immersive, hands-on learning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results